APA (7th ed.) Citation

SJ, L., LJ, Y., HC, W., ZN, D., H, L., X, Z., . . . T, L. (2024). Safety, efficacy, and survival outcomes of immune checkpoint inhibitors rechallenge in patients with cancer: A systematic review and meta-analysis. The oncologist, 29(11), e1425. https://doi.org/10.1093/oncolo/oyae134

Chicago Style (17th ed.) Citation

SJ, Liu, et al. "Safety, Efficacy, and Survival Outcomes of Immune Checkpoint Inhibitors Rechallenge in Patients with Cancer: A Systematic Review and Meta-analysis." The Oncologist 29, no. 11 (2024): e1425. https://doi.org/10.1093/oncolo/oyae134.

MLA (9th ed.) Citation

SJ, Liu, et al. "Safety, Efficacy, and Survival Outcomes of Immune Checkpoint Inhibitors Rechallenge in Patients with Cancer: A Systematic Review and Meta-analysis." The Oncologist, vol. 29, no. 11, 2024, p. e1425, https://doi.org/10.1093/oncolo/oyae134.